Verinata Health Sues Sequenom Over Prenatal Diagnostic Patent Rights | GenomeWeb

Verinata Health said last week that it is seeking a declaratory judgment from a federal court that its sequencing-based methods for prenatal diagnostics do not infringe on a patent held by Sequenom.

Also included in the action, which was filed in the US District Court for the Northern District of California, are claims alleging that Sequenom infringes on two patents held by Stanford University and licensed to Verinata: US Patent Nos 7,888,017 and 8,008,018.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.